Cost-Effectiveness of Liraglutide Versus Dapagliflozin for the Treatment of Patients with Type-2 Diabetes Mellitus in the UK
Abstract
Authors
M Schlueter G Vega-Hernandez R Wojcik
M Schlueter G Vega-Hernandez R Wojcik
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now